Treatment of Group A Streptococcal Skin Infections
For Group A streptococcal skin infections, penicillin is the drug of choice, with amoxicillin being preferred in young children due to better taste acceptance at a dosage of 40-50 mg/kg/day divided into 3 doses for 10 days. 1
First-line Treatment Options
For Non-Allergic Patients:
Oral therapy:
Parenteral therapy (for severe infections or patients unable to take oral medications):
For Penicillin-Allergic Patients:
- Erythromycin estolate: 20-40 mg/kg/day divided 2-3 times daily for 10 days 3, 5
- Erythromycin ethylsuccinate: 40 mg/kg/day divided 2-3 times daily for 10 days 3, 5
- Clindamycin: 600-900 mg every 8 hours (for adults) 3
Treatment Considerations
Infection Severity
Mild to moderate infections:
- Oral therapy is generally sufficient
- Complete the full 10-day course even if symptoms resolve earlier 1
Severe infections:
- Consider parenteral therapy, especially for:
- Extensive skin involvement
- Systemic symptoms
- Inability to take oral medications
- Poor compliance concerns
- Consider parenteral therapy, especially for:
Special Populations
- Young children: Amoxicillin is preferred over penicillin V due to better taste acceptance 1
- Immunocompromised patients: Consider broader coverage or higher doses
Duration of Therapy
- A full 10-day course is recommended to eradicate the organism and prevent complications, even if symptoms resolve earlier 3, 1
- Exception: Azithromycin can be given for 5 days if used as an alternative 1
Adjunctive Measures
- Analgesics/antipyretics for moderate to severe symptoms or high fever 1
- Wound care for open lesions
- Avoid corticosteroids as adjunctive therapy 1
Treatment Failures and Recurrences
- Recurrences occur in approximately 20% of cases 1
- For treatment failures:
- Consider compliance issues
- Evaluate for penicillin-resistant organisms (particularly coexisting Staphylococcus)
- Consider switching to a broader-spectrum agent like clindamycin 3
Important Clinical Pearls
Recent studies have shown erythromycin may be superior to penicillin for streptococcal skin infections, possibly due to increasing numbers of penicillin-resistant staphylococci found in these lesions 5
Testing or treating asymptomatic household contacts is not routinely recommended 1
For mixed infections with both streptococci and staphylococci, consider broader coverage with agents effective against both pathogens, such as amoxicillin-clavulanate or clindamycin 6
In areas with high prevalence of methicillin-resistant Staphylococcus aureus (MRSA), empiric coverage may need to include agents active against MRSA if there is concern for mixed infection 3
Topical antibiotics may be useful in preventing streptococcal pyoderma, especially in children known to be at increased risk for such infection 7